業績一覧

ACHIEVEMENT LIST

  • Tsujikawa T, Ohno K, Morita KI, Saburi S, Mitsuda J, Yoshimura K, Kimura A, Morimoto H, Ogi H, Shibata S, Akashi T, Kurata M, Imoto I, Shimizu Y, Kano S, Watanabe A, Yamazaki T, Asada Y, Hayashi R, Saito Y, Ozawa H, Tsukahara K, Oridate N, Sano D, Horii A, Ueki Y, Maruo T, Mukoyama N, Hanai N, Fukusumi T, Iwai H, Fujisawa T, Fujii T, Nibu KI, Iwae S, Ueda T, Chikuie N, Yasumatsu R, Matsuo M, Umeno H, Ono T, Masuda M, Toh S, Itoh K, Hirano S, Asakage T: Clinical, genomic and immune microenvironmental determinants of nivolumab response in head and neck squamous cell carcinoma

    Front Immunol. 15: 1390873, 2024

  • Hatanaka KC, Nakamura K, Katoh R, Ito K, Hirokawa M, Miyauchi A, Matsuno Y, Kano S, Okada Y, Mori J, Ito YM, Hatanaka Y: Impact of the quality of resected thyroid cancer tissue sample on next-generation sequencing testing

    Pathol Int. 74(2): 77-86, 2024

  • Fushimi C, Takahashi H, Kawakita D, Kano S, Tsukahara K, Ozawa H, Okami K, Sakai A, Yamazaki K, Okada T, Hanazawa T, Sato Y, Imanishi Y, Shimizu A, Matsuki T, Nagao T, Tada Y: Brain metastases in patients with salivary duct carcinoma: A retrospective study

    Cancer Med. 13(5): e7037, 2024

  • Honma Y, Monden N, Yamazaki K, Kano S, Satake H, Kadowaki S, Utsumi Y, Nakatogawa T, Takano R, Fujii K, Koroki Y, Aoyama J, Ouchi S, Ogawa T, McCarthy S, Brookman-May SD, Mundle S, Li J, Thaper D, Nagao T, Tada Y: Apalutamide and Goserelin for Androgen Receptor-Positive Salivary Gland Carcinoma: A Phase II Nonrandomized Clinical Trial, YATAGARASU

    Clin Cancer Res. 30(16): 3416-3427, 2024

  • Yaguchi H, Abe M, Fujiwara K, Kudo A, Naganuma R, Uwatoko H, Shirai S, Iwata I, Matsushima M, Yabe I: A patient presenting downbeat positioning nystagmus with 19/11 CAG repeats in the CACNA1A gene: A case report

    Neurol Clin Neurosci. 12: 359-362, 2024

  • Kitoh R, Nishio SY, Sato H, Ikezono T, Morita S, Wada T, Usami SI; Research Group on Intractable Hearing Disorders and Japan Audiological Society: Clinical practice guidelines for the diagnosis and management of acute sensorineural hearing loss

    Auris Nasus Larynx. 51(4): 811-821, 2024

  • Nomura T, Iwata I, Kimura S, Yabe I: Pembrolizumab-induced immune-related bilateral vocal cord paralysis

    Intern Med. 63(22): 3115-3116, 2024

  • Homma A, Ando M, Hanai N, Harada H, Honma Y, Kanda T, Kano S, Kawakita D, Kiyota N, Kizawa Y, Nakagawa M, Ogawa T, Shinomiya H, Shinozaki T, Suzuki M, Tsuji T, Yasuda K, Zenda S, Kodaira T, Kirita T, Nibu K: Summary of Japanese clinical practice guidelines for head and neck cancer – 2022 update edited by the Japan society for head and neck cancer

    Auris Nasus Larynx. 51(1):174-188, 2023

  • Kano S, Suzuki T, Yoshida D, Tsushima N, Hamada S, Yasuda K, Uchinami Y, Aoyama H, Homma A: The superselective intra arterial infusion of cisplatin and concomitant radiotherapy (RADPLAT) is efective for metastatic lymph nodes in head and neck squamous cell carcinoma

    Int J Clin Oncol. 28(9): 1121-1128, 2023

  • Fujiwara K, Morita S, Fukuda A, Hoshino K, Nakamaru Y, Homma A: Discrepancies in the caloric testing and video Head Impulse Test results in a case with bilateral lateral semicircular canal malformations.

    Auris Nasus Larynx. 50(3): 463-467, 2023

次ページへ » もっと見る